First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study
| Autor: | Feher, O. *, Vodvarka, P., Jassem, J., Morack, G., Advani, S.H., Khoo, K.S., Doval, D.C., Ermisch, S., Roychowdhury, D., Miller, M.A., von Minckwitz, G. |
|---|---|
| Zdroj: | In Annals of Oncology June 2005 16(6):899-908 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|